Concepedia

Author

Doron Zahger

Ben-Gurion University of the NegevORCID

Also Known As

Barbra Dalton, D Zahger, D. Zahger, DORON ZAHGER, Denis Xavier, Doron Zagher, Doron Zahger, Eric A. Shry, Petr Widimsky, W. Wijns

212

Publications

17.4K

Citations

39

H-Index

91

Concepts

All Affiliations

Ben-Gurion University of the NegevSoroka Medical CenterSheba Medical CenterTel Aviv UniversityRabin Medical Center
DZ

About

Doron Zahger is an author at Ben-Gurion University of the Negev specializing in medicine, cardiovascular disease, and emergency medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

48

2.7K

2

Public Health

19

25

1.3K

3

Engineering

1

1

122

4

Health Sciences

1

1

199

5

Humanities

1

1

13

Doron Zahger

×

81

Publications

4.7K

Citations

35

H-Index

YearCitations

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

Vera Bittner, Michael Szarek, Philip E. Aylward,

Journal of the American College of Cardiology

2020

545

Myocardial infarction after vascular surgery: the role of prolonged, stress-induced, ST depression-type ischemia

Giora Landesberg, Morris Mosseri, Doron Zahger,

Journal of the American College of Cardiology

2001

237

ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation

Philippe Gabríel Steg, Stefan James, Dan Atar,

Revista Española de Cardiología (English Edition)

2012

213

Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology

Uwe Zeymer, Héctor Bueno, Christopher B. Granger,

European Heart Journal Acute Cardiovascular Care

2020

204

Psoriasis and the Metabolic Syndrome

AD Cohen, Harel Gilutz, Y Henkin,

Acta Dermato Venereologica

2007

199

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial

Michael Szarek, Vera Bittner, Philip E. Aylward,

European Heart Journal

2020

193

Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial

Bojan Cercek, Prediman K. Shah, Marko Noč,

The Lancet

2003

170

Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association

Janina Stępińska, M. Lettino, Ingo Ahrens,

European Heart Journal Acute Cardiovascular Care

2020

157

Incidence, Risk Factors, Management and Outcomes of Coronary Artery Perforation During Percutaneous Coronary Intervention

Avi Shimony, Doron Zahger, Michael van Straten,

The American Journal of Cardiology

2009

154

Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial

Guy Amit, Carlos Cafri, Sergei Yaroslavtsev,

American Heart Journal

2006

125

Page 1